65 related articles for article (PubMed ID: 10810346)
1. 1,25-dihydroxyvitamin D3 dissolved in lipiodol produces a sustained antiproliferative effect in the human hepatoblastoma cell line HepG2.
Pourgholami MH; Akhter J; Finlay IG; Morris DL
Anticancer Res; 2000; 20(2A):723-7. PubMed ID: 10810346
[TBL] [Abstract][Full Text] [Related]
2. In vitro antiproliferative activity of a medium-chain triglyceride solution of 1,25-dihydroxyvitamin D3 in HepG2 cells.
Pourgholami MH; Akhter J; Morris DL
Anticancer Res; 2000; 20(6B):4257-60. PubMed ID: 11205255
[TBL] [Abstract][Full Text] [Related]
3. Fish oil enhances the antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 on liver cancer cells.
Chiang KC; Persons KS; Istfan NW; Holick MF; Chen TC
Anticancer Res; 2009 Sep; 29(9):3591-6. PubMed ID: 19667153
[TBL] [Abstract][Full Text] [Related]
4. Hepatic intra-arterial injection of lipiodol-1,25-dihydroxyvitamin D3 for hepatocellular carcinoma in rats.
Jourdan JL; Akhter J; Bowrey P; Pourgholami M; Morris DL
Anticancer Res; 2000; 20(4):2739-44. PubMed ID: 10953352
[TBL] [Abstract][Full Text] [Related]
5. The use of lipiodol and medium chain triglyceride as delivery agents for hepatic arterial administration of 1, 25-dihydroxyvitamin D3--a potential new treatment for hepatocellular carcinoma.
Finlay IG; Stewart GJ; Pourgholami MH; Akhter J; Morris DL
Anticancer Res; 2000; 20(4):2705-9. PubMed ID: 10953347
[TBL] [Abstract][Full Text] [Related]
6. 1alpha,25-Dihydroxyvitamin D3 and its analogues, EB1089 and CB1093, profoundly inhibit the in vitro proliferation of the human hepatoblastoma cell line HepG2.
Akhter J; Lu Y; Finlay I; Pourgholami MH; Morris DL
ANZ J Surg; 2001 Jul; 71(7):414-7. PubMed ID: 11450917
[TBL] [Abstract][Full Text] [Related]
7. 1,25-Dihydroxyvitamin D3 in lipiodol for the treatment of hepatocellular carcinoma: cellular, animal and clinical studies.
Pourgholami MH; Morris DL
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):513-8. PubMed ID: 15225830
[TBL] [Abstract][Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
9. The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growth.
Gavrilov V; Steiner M; Shany S
Anticancer Res; 2005; 25(5):3425-9. PubMed ID: 16101159
[TBL] [Abstract][Full Text] [Related]
10. Uptake of Lipiodol--cytotoxic conjugates by hepatoblastoma cells.
Towu E; Al-Mufti R; Spitz L; Marron K; Winslet M
Br J Surg; 2002 Apr; 89(4):437-41. PubMed ID: 11952584
[TBL] [Abstract][Full Text] [Related]
11. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
12. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
Miyahara T; Simoura T; Osahune N; Uchida Y; Sakuma T; Nemoto N; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Chiba H; Iba K; Sawada N
Calcif Tissue Int; 2002 Jun; 70(6):488-95. PubMed ID: 12016462
[TBL] [Abstract][Full Text] [Related]
13. Lipiodol ultra-fluid: an antitumor agent-in vitro study.
Durand-Fontanier S; Simon A; Duroux JL; Descottes B; Delage C
Anticancer Res; 1999; 19(5B):4357-61. PubMed ID: 10628401
[TBL] [Abstract][Full Text] [Related]
14. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2].
Lu HQ; Zheng J
Ai Zheng; 2006 Dec; 25(12):1470-6. PubMed ID: 17166369
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo inhibition of liver cancer cells by 1,25-dihydroxyvitamin D3.
Pourgholami MH; Akhter J; Lu Y; Morris DL
Cancer Lett; 2000 Apr; 151(1):97-102. PubMed ID: 10766428
[TBL] [Abstract][Full Text] [Related]
16. Amphiregulin is a vitamin D3 target gene in squamous cell and breast carcinoma.
Akutsu N; Bastien Y; Lin R; Mader S; White JH
Biochem Biophys Res Commun; 2001 Mar; 281(4):1051-6. PubMed ID: 11237771
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
18. Additive immunosuppressive effects of 1,25-dihydroxyvitamin D3 and corticosteroids on TH1, but not TH2, responses.
Jirapongsananuruk O; Melamed I; Leung DY
J Allergy Clin Immunol; 2000 Nov; 106(5):981-5. PubMed ID: 11080724
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hepatocellular cancer by EB1089: in vitro and in vive study.
Ghous Z; Akhter J; Pourgholami MH; Morris DL
Anticancer Res; 2008; 28(6A):3757-61. PubMed ID: 19189661
[TBL] [Abstract][Full Text] [Related]
20. Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191).
Wietrzyk J; Pełczyńska M; Madej J; Dzimira S; Kuśnierczyk H; Kutner A; Szelejewski W; Opolski A
Steroids; 2004 Sep; 69(10):629-35. PubMed ID: 15465107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
